201 related articles for article (PubMed ID: 16052522)
1. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
[TBL] [Abstract][Full Text] [Related]
2. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
4. SPARC enhances tumor stroma formation and prevents fibroblast activation.
Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
[TBL] [Abstract][Full Text] [Related]
5. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastoma.
Gorantla B; Bhoopathi P; Chetty C; Gogineni VR; Sailaja GS; Gondi CS; Rao JS
Angiogenesis; 2013 Jan; 16(1):85-100. PubMed ID: 22956186
[TBL] [Abstract][Full Text] [Related]
7. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
8. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
[TBL] [Abstract][Full Text] [Related]
9. Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer.
Zhang JL; Chen GW; Liu YC; Wang PY; Wang X; Wan YL; Zhu J; Gao HQ; Yin J; Wang W; Tian ML
PLoS One; 2012; 7(9):e44618. PubMed ID: 22957090
[TBL] [Abstract][Full Text] [Related]
10. The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.
Bhoopathi P; Chetty C; Gujrati M; Dinh DH; Rao JS; Lakka SS
Br J Cancer; 2010 Feb; 102(3):530-40. PubMed ID: 20087345
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
Zeng G; Gao L; Birklé S; Yu RK
Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051
[TBL] [Abstract][Full Text] [Related]
12. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
13. Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.
Chlenski A; Dobratic M; Salwen HR; Applebaum M; Guerrero LJ; Miller R; DeWane G; Solomaha E; Marks JD; Cohn SL
Oncotarget; 2016 Nov; 7(47):77696-77706. PubMed ID: 27776337
[TBL] [Abstract][Full Text] [Related]
14. SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.
Haber CL; Gottifredi V; Llera AS; Salvatierra E; Prada F; Alonso L; Sage EH; Podhajcer OL
Int J Cancer; 2008 Apr; 122(7):1465-75. PubMed ID: 18059024
[TBL] [Abstract][Full Text] [Related]
15. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.
Cydzik M; Abdul-Wahid A; Park S; Bourdeau A; Bowden K; Prodeus A; Kollara A; Brown TJ; Ringuette MJ; Gariépy J
FASEB J; 2015 Aug; 29(8):3493-505. PubMed ID: 25921830
[TBL] [Abstract][Full Text] [Related]
16. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.
Brekken RA; Puolakkainen P; Graves DC; Workman G; Lubkin SR; Sage EH
J Clin Invest; 2003 Feb; 111(4):487-95. PubMed ID: 12588887
[TBL] [Abstract][Full Text] [Related]
17. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
Wong SY; Crowley D; Bronson RT; Hynes RO
Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
[TBL] [Abstract][Full Text] [Related]
20. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
